YONGTAI TECH.(SZ:002326)2022-12-04 10:14Group 1: Company Overview - The company is a leading manufacturer of fluorobenzene fine chemicals with a complete product chain and global production capacity [1] - In the first nine months of 2019, the company achieved sales revenue of CNY 266,808.14 million, a year-on-year increase of 26.18% [1] - The net profit from non-recurring gains and losses was CNY 27,128.43 million, up 71.84% year-on-year, driven by abundant orders and improved gross profit margin [2] Group 2: Core Competencies - The majority of the company's product varieties can be sold independently, showcasing strong market adaptability and significant potential for product structure upgrades [2] - The company has implemented a production model that utilizes by-products to create higher-value products, reducing overall production costs [2] - The company follows a growth strategy of "internal growth and external expansion," extending its pharmaceutical and pesticide chains into high-value downstream areas [2][3] Group 3: Future Development Strategy - The company aims to enhance existing production facilities, improve management levels, and increase R&D and environmental standards [3] - There is a focus on deepening relationships with key customers and exploring their needs to ensure sustainable internal growth [3] - The company plans to leverage its capital market advantages for both internal growth and external development [3] Group 4: Market Prospects and Product Development - The lithium difluorosulfamide has a promising market outlook due to its advantages over lithium hexafluorophosphate, despite current reliance on imports [4] - The production workshop for lithium difluorosulfamide is progressing well, with small-scale production and ongoing product certification discussions with downstream clients [4] - The approval of Rosuvastatin Calcium Tablets by the FDA marks the company's qualification to sell in the U.S. market, positively impacting its performance [4] Group 5: Future Growth Points - The company anticipates steady growth from traditional products and collaborative development across its entire industrial chain [5] - Multiple projects are set to commence production, ensuring the company enters a fast growth phase, including the upcoming launch of lithium difluorosulfamide [5] - The ongoing construction of production bases in areas like Linhai and planned investments in Inner Mongolia will enhance the company's competitive edge in the fine chemical sector [5]